Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension
CRYSTAL-CO
A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With DM Related Complication and Hypertension.
1 other identifier
observational
2,000
1 country
13
Brief Summary
This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2008
Shorter than P25 for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2008
CompletedFirst Posted
Study publicly available on registry
October 10, 2008
CompletedStudy Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedDecember 3, 2010
December 1, 2010
4 months
October 9, 2008
December 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Attainment rate to the target blood pressure.
After collecting all Patient Record Form.
Secondary Outcomes (3)
Attainment to the target blood pressure will be investigated according to DM related complications.
After collecting all Patient Record Form.
Change in the DBP/SBP value will be investigated according to the DM Complication
After collecting all Patient Record Form.
Treatment pattern and factors that affect BP control
After collecting all Patient Record Form.
Study Arms (1)
1
Type II Diabetes Mellitus patients with Complication and Hypertension
Eligibility Criteria
Type II Diabetes Mellitus patients with Complication and Hypertension
You may qualify if:
- After diagnosed type II DM, patients received treatment for a least 3 years
- Type II DM patients with hypertension and its complication.
- Visited out-patients to care center after 1 Jan. 2008
You may not qualify if:
- Secondary hypertension patients
- Patients not receiving hypertension medication
- Patients stopping BP medication, by physician's order
- Patients currently enrolled in other clinical studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (13)
Research Site
Wŏnju, Gangwon-do, South Korea
Research Site
Bucheon-si, Gyeonggi-do, South Korea
Research Site
Goyang-si, Gyeonggi-do, South Korea
Research Site
Guri-si, Gyeonggi-do, South Korea
Research Site
Sungnam, Gyeonggi-do, South Korea
Research Site
Suwon, Gyeonggi-do, South Korea
Research Site
Jeonju, Keollabuk, South Korea
Research Site
Busan, South Korea
Research Site
Deagu, South Korea
Research Site
Deajeon, South Korea
Research Site
Incheon, South Korea
Research Site
Kwangju, South Korea
Research Site
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Joonwoo Bahn
Astrazenca Korea
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 9, 2008
First Posted
October 10, 2008
Study Start
November 1, 2008
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
December 3, 2010
Record last verified: 2010-12